Replies to post #15878 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Update prediction: "We've decided to throw a lot more money at the necuparanib program."

Fortunately, no. The program has been discontinued (officially, this time):

https://www.sec.gov/Archives/edgar/data/1235010/000110465916142662/a16-17010_38k.htm